Medulloblastoma: A Complete Guide for Parents
Receiving the news that your child may have a brain tumor is one of the most difficult moments a family can experience. Among childhood brain tumors, Medulloblastoma is the most common malignant (cancerous) brain tumor in children. Although this diagnosis can be overwhelming, advances in pediatric neuro-oncology, neurosurgery, chemotherapy, radiation therapy, and supportive care have significantly improved treatment outcomes over the past two decades.
With early diagnosis, expert multidisciplinary care, and individualized treatment planning, many children with Medulloblastoma can be treated successfully and go on to lead active, fulfilling lives.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, children with Medulloblastoma are cared for through a collaborative approach involving the Neuro-Oncology Department, Pediatric Hemato-Oncology Department, Neurosurgery, Radiation Oncology, Neuroradiology, Neuropathology, Rehabilitation Medicine, and specialized pediatric oncology support services. Every child’s treatment plan is designed to achieve the best possible medical outcome while preserving neurological function and quality of life.
What Is Medulloblastoma?
Medulloblastoma is a malignant tumor that develops in the cerebellum, the part of the brain responsible for balance, coordination, and fine motor control. It belongs to a group of tumors known as embryonal tumors and arises from immature cells of the central nervous system.
Unlike many other childhood cancers, Medulloblastoma has the potential to spread through the cerebrospinal fluid (CSF) to other areas of the brain and spinal cord. For this reason, timely diagnosis, accurate staging, and comprehensive treatment are essential.
Medulloblastoma is the most common malignant brain tumor in children. It usually develops in the cerebellum and may cause persistent headaches, morning vomiting, balance problems, vision changes, and difficulty walking. Diagnosis typically involves MRI, surgery, pathological examination, and molecular testing. Treatment may include surgery, chemotherapy, radiation therapy, rehabilitation, and long-term follow-up. Early diagnosis and multidisciplinary care from specialists in Neuro-Oncology, Pediatric Hemato-Oncology, Neurosurgery, and Radiation Oncology play an important role in treatment planning and recovery.
Who Is at Risk?
Medulloblastoma is most commonly diagnosed in:
- Children between 3 and 9 years of age
- Boys slightly more often than girls
- Rarely, adolescents and adults
In most children, the exact cause is unknown. Current evidence suggests that Medulloblastoma develops because of genetic changes within developing brain cells. These changes usually occur spontaneously and are not caused by parenting, diet, minor head injuries, or routine childhood activities.
Rare inherited genetic syndromes can increase the risk in some children, but these account for only a small proportion of cases.
Signs and Symptoms of Medulloblastoma
Because Medulloblastomas often arise in the cerebellum and may block the normal flow of cerebrospinal fluid, symptoms are commonly related to increased pressure inside the skull and impaired balance.
Parents should seek medical evaluation if a child develops persistent or progressive symptoms such as:
Persistent Headaches
Headaches that:
- Occur repeatedly
- Are worse in the morning
- Wake the child from sleep
- Increase in intensity over time
require prompt assessment.
Recurrent Morning Vomiting
Vomiting without an obvious stomach illness, especially on waking, can be an important warning sign.
Balance and Coordination Problems
Children may experience:
- Frequent falls
- Difficulty walking
- Unsteady gait
- Clumsiness
- Poor coordination
Double Vision or Vision Changes
Pressure within the brain can affect the nerves controlling eye movements, resulting in blurred or double vision.
Abnormal Eye Movements
Parents may notice unusual eye movements or difficulty focusing.
Fatigue and Excessive Sleepiness
As pressure within the brain increases, children may become unusually sleepy, irritable, or less active.
Changes in School Performance
Older children may develop:
- Difficulty concentrating
- Memory problems
- Declining academic performance
- Behavioural changes
Seizures
Although less common than in some other brain tumors, seizures can occur and require immediate medical evaluation.
When Should Parents Consult a Specialist?
Any child with persistent headaches, repeated vomiting, unexplained balance problems, vision changes, or new neurological symptoms should be evaluated promptly. While these symptoms can have many causes, early assessment by specialists is important to identify serious conditions such as brain tumors and begin appropriate treatment without unnecessary delay.
Why Early Diagnosis Matters
Medulloblastoma can grow relatively quickly. Early diagnosis offers several potential benefits:
- Earlier treatment planning
- Relief of pressure within the brain
- Better opportunity for safe surgical removal
- More accurate staging
- Improved coordination of surgery, chemotherapy, and radiation therapy
- Better long-term functional outcomes
Comprehensive Neuro-Oncology Care at BIACH&RI
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), children with Medulloblastoma are managed through a multidisciplinary model of care.
The team may include:
- Pediatric Hemato-Oncologists
- Neuro-Oncologists
- Pediatric Neurosurgeons
- Radiation Oncologists
- Pediatric Neurologists
- Neuroradiologists
- Neuropathologists
- Pediatric Intensivists
- Pediatric Oncology Nurses
- Rehabilitation Specialists
- Clinical Nutritionists
- Psychologists
- Physiotherapists
- Occupational Therapists
- Speech and Language Therapists
Each case is reviewed in a Multidisciplinary Tumor Board, where imaging, pathology, molecular findings, and the child’s overall condition are discussed to develop an individualized treatment plan based on current international standards.
Diagnosing Medulloblastoma
An early and accurate diagnosis is the foundation of successful treatment. Because Medulloblastoma can grow rapidly and may spread through the cerebrospinal fluid (CSF), every child with suspected disease requires prompt evaluation by specialists experienced in pediatric brain tumors.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, children with suspected Medulloblastoma are evaluated jointly by the Neuro-Oncology Department, Pediatric Hemato-Oncology Department, Neurosurgery Department, Radiation Oncology Department, and other specialists. This coordinated approach helps ensure that each child receives an accurate diagnosis and an individualized treatment plan.
Initial Clinical Assessment
The diagnostic process begins with a detailed consultation.
The medical team will ask about:
- Duration and progression of symptoms
- Persistent headaches
- Morning vomiting
- Balance or walking difficulties
- Vision changes
- Seizures
- Behavioural or learning changes
- Developmental history
- Previous medical conditions
- Family history of neurological or genetic disorders
This information helps guide further investigations.
Neurological Examination
A comprehensive neurological examination helps doctors understand how different areas of the brain are functioning.
The examination may include assessment of:
- Muscle strength
- Balance and coordination
- Walking pattern
- Reflexes
- Eye movements
- Vision
- Hearing
- Speech
- Sensation
- Cranial nerve function
- Cognitive function appropriate for the child’s age
These findings help determine which part of the brain may be affected.
MRI – The Gold Standard Investigation
Magnetic Resonance Imaging (MRI) is the preferred imaging test for children with suspected Medulloblastoma.
MRI provides highly detailed images of:
- The cerebellum
- Brainstem
- Ventricular system
- Surrounding brain tissue
- Cranial nerves
- Spinal cord (when indicated)
MRI helps doctors evaluate:
- Tumor location
- Tumor size
- Relationship to nearby brain structures
- Hydrocephalus (fluid accumulation)
- Compression of surrounding tissue
- Possible spread within the central nervous system
MRI also plays a crucial role in surgical planning and follow-up after treatment.
MRI of the Spine
Because Medulloblastoma can spread through the cerebrospinal fluid, MRI of the entire spine is often recommended as part of the staging process.
This examination helps determine whether tumor cells have spread beyond the brain, which is important for treatment planning.
CT Scan
A CT scan may be performed in emergency situations, particularly when rapid assessment is required.
CT can help identify:
- Hydrocephalus
- Bleeding
- Large masses
- Bone abnormalities
However, MRI remains the preferred imaging modality for detailed evaluation.
Hydrocephalus Assessment
Many children with Medulloblastoma develop hydrocephalus, a condition in which cerebrospinal fluid accumulates because the tumor blocks its normal circulation.
Hydrocephalus may cause:
- Severe headache
- Vomiting
- Drowsiness
- Vision changes
- Irritability
- Difficulty walking
Prompt recognition and management are important to relieve pressure within the brain.
Cerebrospinal Fluid (CSF) Examination
After surgery—and only when considered safe by the treating team—a sample of cerebrospinal fluid may be examined for the presence of tumor cells.
CSF analysis helps determine whether the tumor has spread within the central nervous system and contributes to disease staging.
Surgical Tissue Diagnosis
Although MRI strongly suggests the diagnosis, histopathological examination of tumor tissue is essential to confirm Medulloblastoma.
During surgery, the neurosurgeon removes all or part of the tumor. The tissue is then examined by a Neuropathologist, who determines:
- The exact diagnosis
- Tumor subtype
- Histological characteristics
- Additional features that influence treatment planning
Molecular Classification
Modern pediatric neuro-oncology has transformed the understanding of Medulloblastoma.
Today, treatment planning is based not only on what the tumor looks like under the microscope but also on its molecular characteristics.
Current international classifications recognize several major molecular groups, including:
- WNT-activated
- SHH-activated
- Group 3
- Group 4
Each group has distinct biological behaviour, expected outcomes, and treatment considerations.
Molecular classification has become an important component of precision medicine in pediatric brain tumors.
WHO Classification
Medulloblastoma is classified according to the World Health Organization (WHO) Classification of Central Nervous System Tumors, which integrates:
- Histological appearance
- Molecular findings
- Genetic alterations
This standardized approach helps specialists select the most appropriate treatment strategy.
Risk Stratification
Not every child with Medulloblastoma receives the same treatment.
After surgery and staging, the healthcare team assesses several factors, including:
- Age
- Extent of tumor removal
- Presence or absence of metastatic disease
- Molecular subtype
- Histopathological findings
These factors help classify the disease into risk groups and guide decisions regarding chemotherapy, radiation therapy, and long-term follow-up.
Multidisciplinary Tumor Board
One of the strengths of Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI) is its multidisciplinary approach to pediatric brain tumors.
Each child’s diagnosis and treatment plan may be reviewed by a Multidisciplinary Tumor Board, which brings together specialists from:
- Neuro-Oncology
- Pediatric Hemato-Oncology
- Neurosurgery
- Radiation Oncology
- Neuroradiology
- Neuropathology
- Pediatric Neurology
- Pediatric Intensive Care
- Rehabilitation Medicine
- Clinical Nutrition
- Psychology
- Pediatric Oncology Nursing
By combining expertise from multiple specialties, the team develops a personalized treatment plan based on current scientific evidence and internationally accepted clinical guidelines.
This collaborative model supports comprehensive, coordinated care from diagnosis through long-term follow-up.
Why Specialized Neuro-Oncology Care Matters
Medulloblastoma is one of the most complex childhood cancers. Successful treatment requires expertise that extends beyond surgery alone.
A dedicated Neuro-Oncology program provides:
- Accurate diagnosis
- Advanced neuroimaging
- Expert neurosurgical planning
- Evidence-based chemotherapy
- Precision radiation therapy planning
- Molecular pathology
- Rehabilitation services
- Long-term survivorship care
This integrated approach helps optimize treatment while supporting neurological function, growth, learning, and quality of life.
Individualized Treatment for Every Child
No two children with Medulloblastoma are exactly alike. The treatment plan is personalized based on several important factors, including:
- The child’s age
- Tumor size and location
- Extent of surgical removal
- Molecular subtype
- Risk classification
- Whether the tumor has spread within the brain or spinal cord
- Overall health of the child
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, every child benefits from coordinated care delivered through the Neuro-Oncology Department, Pediatric Hemato-Oncology Department, Neurosurgery Department, Radiation Oncology Department, and other specialized services. Each treatment plan is developed through multidisciplinary discussions using internationally accepted treatment guidelines.
The primary objectives are to:
- Achieve the best possible tumor control.
- Preserve neurological function.
- Minimize treatment-related complications.
- Support normal growth and development.
- Maximize long-term quality of life.
Pediatric Brain Tumor Surgery
Surgery is usually the first major step in treating Medulloblastoma.
The goals of surgery include:
- Confirming the diagnosis through tissue examination.
- Removing as much of the tumor as safely possible.
- Relieving pressure within the brain.
- Improving symptoms caused by the tumor.
- Creating the best conditions for further treatment.
The amount of tumor that can be removed depends on its location and relationship to vital brain structures. Neurosurgeons carefully balance effective tumor removal with preservation of important functions such as movement, coordination, speech, and swallowing.
The Role of Pediatric Neurosurgery
Children are not simply “small adults.” Brain tumor surgery in children requires expertise in the anatomy and physiology of the developing brain.
Pediatric neurosurgical care focuses on:
- Detailed preoperative planning.
- Safe surgical techniques.
- Preservation of critical neurological function.
- Minimizing complications.
- Supporting recovery after surgery.
Whenever feasible, the surgical goal is maximum safe resection, meaning removal of as much tumor as possible while protecting healthy brain tissue.
Neuro-Oncology: Coordinating Comprehensive Brain Tumor Care
Following surgery, the Neuro-Oncology Department plays a central role in coordinating ongoing treatment.
Neuro-Oncology specialists work closely with Pediatric Hemato-Oncologists, Neurosurgeons, Radiation Oncologists, and rehabilitation teams to:
- Review surgical outcomes.
- Interpret pathology and molecular findings.
- Assess disease risk.
- Plan chemotherapy and radiation therapy when required.
- Monitor treatment response.
- Manage neurological symptoms and long-term follow-up.
This multidisciplinary coordination ensures continuity of care throughout the child’s treatment journey.
Chemotherapy
Chemotherapy is an important component of treatment for many children with Medulloblastoma.
It uses carefully selected anti-cancer medicines to destroy remaining tumor cells after surgery and reduce the risk of recurrence.
The exact chemotherapy regimen depends on:
- The child’s age.
- Risk group.
- Molecular subtype.
- Overall treatment protocol.
Treatment is delivered in carefully planned cycles, with close monitoring to manage side effects and support recovery.
Radiation Therapy
Radiation therapy plays a vital role in the treatment of many children with Medulloblastoma, particularly after surgery.
At BIACH&RI, the Radiation Oncology Department works closely with the Neuro-Oncology and Pediatric Hemato-Oncology teams to develop individualized treatment plans.
Modern radiation planning aims to:
- Deliver radiation accurately to the areas requiring treatment.
- Minimize exposure to healthy tissues whenever possible.
- Reduce the risk of long-term treatment-related effects.
The need for radiation therapy depends on the child’s age, tumor characteristics, and overall treatment plan.
Craniospinal Irradiation
Because Medulloblastoma has the potential to spread through the cerebrospinal fluid, some children may require craniospinal irradiation (CSI) as part of their treatment.
CSI involves treating the brain and spinal cord with carefully planned radiation, followed by an additional focused dose to the original tumor site when indicated.
The decision to use craniospinal irradiation is individualized and based on current pediatric oncology treatment protocols.
Risk-Adapted Therapy
Modern Medulloblastoma treatment is based on risk-adapted therapy, which means treatment intensity is tailored to the individual child.
Factors considered include:
- Extent of tumor removal.
- Presence or absence of metastatic disease.
- Molecular subtype.
- Histopathological findings.
- Age at diagnosis.
This personalized approach aims to provide effective treatment while minimizing unnecessary toxicity.
Precision Medicine
Advances in molecular diagnostics have improved the understanding of Medulloblastoma.
For selected patients, molecular testing may help:
- Refine diagnosis.
- Guide treatment decisions.
- Improve risk assessment.
- Identify eligibility for targeted therapies or clinical trials where appropriate.
Precision medicine continues to play an increasingly important role in pediatric neuro-oncology.
Managing Treatment Side Effects
Children receiving treatment for Medulloblastoma are monitored closely for potential side effects.
Supportive care focuses on:
- Infection prevention.
- Nutritional support.
- Management of nausea and vomiting.
- Blood count monitoring.
- Hormonal evaluation.
- Neurological assessment.
- Hearing and vision monitoring when clinically indicated.
- Emotional and psychological support.
Parents receive education on expected side effects and guidance on when to seek immediate medical attention.
Rehabilitation After Treatment
Recovery begins during treatment and continues long after therapy is completed.
Children may benefit from individualized rehabilitation programs that include:
Physiotherapy
To improve:
- Strength
- Balance
- Walking
- Coordination
Occupational Therapy
To help children regain independence in daily activities and fine motor skills.
Speech and Language Therapy
For children experiencing speech, language, or swallowing difficulties.
Neuropsychological Rehabilitation
Some children may experience changes in:
- Learning
- Memory
- Attention
- Processing speed
- Executive functioning
Assessment and educational support can help children return to school and daily activities.
Psychological Support
A diagnosis of Medulloblastoma affects the entire family.
Counselling services help children and caregivers manage:
- Anxiety
- Emotional stress
- Behavioural changes
- Adjustment during and after treatment
Comprehensive Supportive Care at BIACH&RI
Successful treatment extends beyond surgery, chemotherapy, and radiation therapy.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), comprehensive supportive care may include:
- Pediatric Intensive Care
- Specialized Pediatric Oncology Nursing
- Clinical Nutrition
- Pain and Symptom Management
- Physiotherapy
- Occupational Therapy
- Speech and Language Therapy
- Psychological Counselling
- Social Work Services
- Family Education
- Long-Term Rehabilitation
This multidisciplinary approach aims to support every aspect of the child’s recovery and well-being.
Why a Dedicated Neuro-Oncology Program Is Important
Children with Medulloblastoma require coordinated care from multiple specialists.
A dedicated Neuro-Oncology Program, working in partnership with the Pediatric Hemato-Oncology Department, brings together expertise in diagnosis, surgery, systemic therapy, radiation planning, rehabilitation, and survivorship.
This integrated model supports informed decision-making, seamless coordination between specialties, and individualized care throughout the child’s treatment journey.
Recovery After Medulloblastoma Treatment
Completing treatment for Medulloblastoma is an important milestone, but recovery continues long after surgery, chemotherapy, or radiation therapy. Children require ongoing medical care to monitor brain health, neurological function, growth, learning, hormonal development, and overall well-being.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, follow-up care is delivered through the combined expertise of the Neuro-Oncology Department, Pediatric Hemato-Oncology Department, Neurosurgery Department, Radiation Oncology Department, rehabilitation specialists, pediatric neurologists, psychologists, nutritionists, and pediatric oncology nurses.
The focus is not only on treating the disease but also on helping children achieve the best possible quality of life.
Long-Term Follow-Up
Children treated for Medulloblastoma require regular follow-up visits. The frequency of these visits depends on:
- The child’s age
- Tumor subtype
- Risk group
- Extent of surgery
- Treatment received
- Clinical progress
Follow-up assessments may include:
- Neurological examination
- MRI of the brain
- MRI of the spine, when clinically indicated
- Growth and developmental assessment
- Endocrine evaluation
- Hearing assessment
- Vision assessment
- Neurocognitive evaluation
- Laboratory investigations, when appropriate
- Rehabilitation review
These visits help monitor recovery, identify any recurrence early, and manage potential late effects of treatment.
Can Medulloblastoma Return?
Although many children respond well to treatment, some tumors may recur.
The likelihood of recurrence depends on:
- Molecular subtype
- Risk classification
- Extent of tumor removal
- Response to chemotherapy and radiation therapy
- Presence or absence of metastatic disease
Regular follow-up with the treating team is essential because early detection of recurrence allows timely evaluation and management.
Parents should seek medical attention if a child develops:
- Persistent headaches
- Morning vomiting
- New seizures
- Balance problems
- Vision changes
- Weakness
- Changes in speech
- Difficulty walking
- Unusual behavioural changes
Returning to School
Most children can return to school after treatment, although the timing varies from child to child.
Some children may need:
- A gradual return to school
- Temporary academic adjustments
- Additional educational support
- Speech therapy
- Occupational therapy
- Neuropsychological evaluation
Close communication between parents, teachers, and the healthcare team helps children resume learning with confidence.
Rehabilitation
Rehabilitation is an important part of recovery after Medulloblastoma treatment.
Depending on the child’s needs, rehabilitation may include:
Physiotherapy
To improve:
- Balance
- Walking
- Strength
- Coordination
- Endurance
Occupational Therapy
To assist with:
- Fine motor skills
- Hand function
- Daily activities
- School-related tasks
- Independence
Speech and Language Therapy
For children experiencing:
- Speech difficulties
- Language delays
- Swallowing problems
- Communication challenges
Neuropsychological Rehabilitation
Some children may experience changes in:
- Memory
- Attention
- Learning
- Processing speed
- Executive functioning
Early assessment allows individualized educational planning and cognitive support.
Psychological Counselling
A childhood brain tumor diagnosis affects the emotional well-being of both the child and family.
Counselling services help families cope with:
- Anxiety
- Emotional stress
- Fear of recurrence
- Behavioural changes
- Social adjustment
Long-Term Survivorship
With advances in pediatric neuro-oncology, many children treated for Medulloblastoma become long-term survivors.
Survivorship care focuses on:
- Neurological health
- Physical development
- Endocrine health
- Hearing and vision
- Educational progress
- Emotional well-being
- Nutrition
- Physical activity
- Social development
- Transition to adult healthcare when appropriate
A structured survivorship program helps children thrive beyond cancer treatment.
Frequently Asked Questions (FAQ)
What is Medulloblastoma?
Medulloblastoma is the most common malignant brain tumor in children. It usually develops in the cerebellum, the part of the brain responsible for balance and coordination.
Is Medulloblastoma curable?
Many children with Medulloblastoma can be treated successfully. The outlook depends on factors such as the tumor’s molecular subtype, stage, extent of surgical removal, and response to treatment. Your treating team can provide information specific to your child’s diagnosis.
What are the first symptoms?
Common symptoms include:
- Persistent headaches
- Morning vomiting
- Difficulty walking
- Balance problems
- Double vision
- Excessive sleepiness
- Behavioural changes
- Seizures
Persistent or progressive symptoms should always be evaluated by a doctor.
Is MRI necessary?
MRI is generally the preferred imaging investigation for diagnosing Medulloblastoma and planning treatment because it provides detailed images of the brain and spinal cord.
Does every child need surgery?
Surgery is commonly the first step in treatment. The extent of surgery depends on the tumor’s location and the child’s condition. Additional treatment may include chemotherapy, radiation therapy, or both.
Why is molecular testing important?
Molecular testing helps classify Medulloblastoma into different biological subtypes, which can guide risk assessment and treatment planning.
Why is a multidisciplinary team important?
Children with Medulloblastoma often require care from multiple specialists. A multidisciplinary team combines expertise from Neuro-Oncology, Pediatric Hemato-Oncology, Neurosurgery, Radiation Oncology, Neuroradiology, Neuropathology, Rehabilitation, and supportive care to develop an individualized treatment plan.
Can children return to normal activities?
Many children gradually return to school, sports, and family activities after treatment. Recovery varies depending on the child’s diagnosis, treatment, and rehabilitation needs.
Why Choose Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI)?
Treating Medulloblastoma requires coordinated care from experienced specialists.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, children receive comprehensive care through close collaboration between our Neuro-Oncology Department and Pediatric Hemato-Oncology Department, supported by multiple oncology and neuroscience specialties.
Our multidisciplinary approach includes:
- Pediatric Hemato-Oncology
- Neuro-Oncology
- Pediatric Neurosurgery
- Radiation Oncology
- Medical Oncology
- Neuroradiology
- Neuropathology
- Pediatric Neurology
- Pediatric Intensive Care
- Rehabilitation Medicine
- Physiotherapy
- Occupational Therapy
- Speech and Language Therapy
- Clinical Nutrition
- Pediatric Oncology Nursing
- Clinical Psychology
- Long-Term Survivorship Care
Every child benefits from an individualized treatment plan designed to provide evidence-based care, compassionate support, and continuous follow-up throughout the cancer journey.
Key Takeaways
- Medulloblastoma is the most common malignant brain tumor in children.
- Persistent headaches, morning vomiting, balance problems, and vision changes should never be ignored.
- MRI, surgery, pathology, and molecular testing are essential components of diagnosis.
- Treatment may include surgery, chemotherapy, radiation therapy, rehabilitation, and long-term follow-up.
- Multidisciplinary care from Neuro-Oncology, Pediatric Hemato-Oncology, Neurosurgery, and Radiation Oncology teams supports comprehensive treatment and recovery.
If your child has persistent headaches, repeated morning vomiting, difficulty walking, balance problems, vision changes, or any unexplained neurological symptoms, do not delay seeking medical evaluation. Early diagnosis can significantly influence treatment planning and outcomes.
At Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), Hyderabad, our Neuro-Oncology Department and Pediatric Hemato-Oncology Department provide comprehensive evaluation, advanced diagnostics, multidisciplinary treatment, rehabilitation, and long-term follow-up for children with Medulloblastoma and other pediatric brain tumors. Our team is committed to delivering compassionate, evidence-based care tailored to the unique needs of every child and family.